AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 1, 2026

Breaking the Silence: Bladder Cancer Awareness Month Begins
May 1, 2026

Breaking the Silence: Bladder Cancer Awareness Month Begins

Indeterminate GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
May 1, 2026

Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026

Indeterminate GlobeNewswire
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
May 1, 2026

IRADIMED CORPORATION Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Inspira Secures $596,000 AME System Order from Leading Irish Technological University
May 1, 2026

Inspira Secures $596,000 AME System Order from Leading Irish Technological University

Indeterminate GlobeNewswire
Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)
May 1, 2026

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)

Indeterminate GlobeNewswire
InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
May 1, 2026

InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics

Indeterminate GlobeNewswire
MedAire and NBAA Partner to Bring Peer Support Access to Individual Aviation Professionals
May 1, 2026

MedAire and NBAA Partner to Bring Peer Support Access to Individual Aviation Professionals

Indeterminate GlobeNewswire
Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
May 1, 2026

Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference

Indeterminate GlobeNewswire
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026
May 1, 2026

Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

Indeterminate GlobeNewswire
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
May 1, 2026

Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting

Indeterminate GlobeNewswire
Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
May 1, 2026

Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET

Indeterminate GlobeNewswire
Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
May 1, 2026

Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia

Indeterminate GlobeNewswire
InflaRx to Report First Quarter 2026 Results on May 7, 2026
May 1, 2026

InflaRx to Report First Quarter 2026 Results on May 7, 2026

Indeterminate GlobeNewswire
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
May 1, 2026

Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader

Indeterminate GlobeNewswire
Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting
May 1, 2026

Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting

Indeterminate GlobeNewswire
Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
May 1, 2026

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Indeterminate GlobeNewswire
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
May 1, 2026

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

Indeterminate GlobeNewswire
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
May 1, 2026

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.